Presenting author

Jens Wendland

1 presentation

• W111. A first-in-human study to evaluate safety, pharmacokinetics and pharmacodynamics of KYN-5356, a first-in-class inhibitor of kynurenine aminotransferase II (KAT-II)

  2026 ASCP Annual Meeting